DERMABOND® Mini Topical Skin Adhesive

DERMABOND Mini is a wound closure device that adds strength, provides a protective barrier and inhibits bacteria in small lacerations. It is clinically shown to provide 7-day wound holding strength in just 3 minutes.1 Additionally, DERMABOND Mini provides a microbial barrier with 99% protection in vitro for 72 hours against organisms commonly responsible for surgical site infections (SSI)*2 and demonstrates inhibition of gram-positive bacteria (MRSA and MRSE) and gram-negative bacteria (E coli) in vitro.†3

DERMABOND® MINI

Product Specifications

Product Code

Product Code

Description

 
DHVM12 DHVM12 DERMABOND MINI TOPICAL SKIN ADHESIVE - 2-OCTYLCYANOACRYLATE HIGH VISCOSITY FORMULATION FOR SMALL INCISIONS AND LACERATIONS; 0.36ML ADHESIVE VOLUME 

Supporting Documentation

Clinical Evidence

DERMABOND Mini Topical Skin Adhesive Clinical Evidence Brief

Product Support

DERMABOND Portfolio Value Proposition

DERMABOND Mini Topical Skin Adhesive Fact Sheet

References

*S. epidermidis, E. coli, S. aureus, P. aeruginosa, E. faecium.

†Clinical significance unknown.

1. Quinn J, Wells G, Sutclie T, et al. A randomized trial comparing octylcyanoacrylate tissue adhesive and sutures in the management of lacerations. JAMA. 1997;277:1527-1530.

2. Bhende S, Rothenburger S, Spangler DJ, Dito M. In vitro assessment of microbial barrier properties of DERMABOND® Topical Skin Adhesive. Surg Infect. 2002;3(3):251-257.

3. In vitro evaluation of the viability of microorganisms after direct contact with DERMABOND® Topical Skin Adhesive. 2010

For complete indications, contraindications, warnings, precautions, and adverse reactions, please reference full package insert.